Detailed Information on Publication Record
2010
Prognostic factors and treatment outcome in 1,516 adult patients with de novo and secondary acute myeloid leukemia in 1999-2009 in 5 hematology intensive care centers in the Czech Republic
SZOTKOWSKI, Tomáš, Jan MUŽÍK, Jaroslava VOGLOVÁ, V. KOZA, J. MAALOUFOVA et. al.Basic information
Original name
Prognostic factors and treatment outcome in 1,516 adult patients with de novo and secondary acute myeloid leukemia in 1999-2009 in 5 hematology intensive care centers in the Czech Republic
Authors
SZOTKOWSKI, Tomáš (203 Czech Republic, guarantor), Jan MUŽÍK (203 Czech Republic, belonging to the institution), Jaroslava VOGLOVÁ (203 Czech Republic), V. KOZA (203 Czech Republic), J. MAALOUFOVA (203 Czech Republic), Tomáš KOZÁK (203 Czech Republic), Marie JAROŠOVÁ (203 Czech Republic), Kyra MICHALOVÁ (203 Czech Republic), Pavel ŽÁK (203 Czech Republic), Kateřina STEINEROVÁ (203 Czech Republic), J. VYDRA (203 Czech Republic), M. LÁNSKÁ (203 Czech Republic), B. KATRINCSÁKOVÁ (203 Czech Republic), Kateřina SIČOVÁ (203 Czech Republic), Tomáš PAVLÍK (203 Czech Republic, belonging to the institution), Ladislav DUŠEK (203 Czech Republic, belonging to the institution) and Karel INDRÁK (203 Czech Republic, belonging to the institution)
Edition
Neoplasma, 2010, 0028-2685
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30200 3.2 Clinical medicine
Country of publisher
Slovakia
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 1.449
RIV identification code
RIV/00216224:14710/10:00051571
Organization unit
Institute of Biostatistics and Analyses
UT WoS
000286494400012
Keywords in English
Acute myeloid leukemia; prognostic factors; consolidation; stem cell transplantation; treatment outcome; registry
Tags
International impact, Reviewed
Změněno: 18/4/2012 10:38, RNDr. Tomáš Pavlík, Ph.D.
Abstract
V originále
Acute myeloid leukemia (AML) is a severe condition with a high mortality. When making decisions about the optimal tailor-made therapy, numerous prognostic factors are considered. The study represents a detailed analysis of the role of these factors and treatment outcomes based on a long-term follow-up of patients treated in 5 hematology intensive care centers in the Czech Republic.